(Q41698429)

7 October 2017

1 reference

title

Review: analogies between trophoblastic and malignant cells (English)

1 reference

7 October 2017

Mullen CA

1

1 reference

7 October 2017

publication date

1 January 1998

1 reference

American Journal of Reproductive Immunology

7 October 2017

published in

1 reference

7 October 2017

volume

39

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

41-49

1 reference

Distribution of β2 microglobulin and HLA in chorionic villi of human placentae

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

HLA expression in hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Nonclassical HLA-G molecules are classical peptide presenters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

A class I antigen, HLA-G, expressed in human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

The role of IL-10 in crossregulation of TH1 and TH2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

A Role for CD4+T-Cell Subsets Producing a Selective Pattern of Lymphokines in the Pathogenesis of Human Chronic Inflammatory and Allergic Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Regulation of the immune response by prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Direct immunochemical detection of prostaglandin-e and cyclic nucleotides in human malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

The transforming growth factor-betas: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Transforming growth factor-beta 1 expression during placental development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Receptors for the TGF-β family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Retinoblastoma protein switches the E2F site from positive to negative element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Immunotherapy for recurrent spontaneous abortion and its analogies to treatment for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Regulation of immunity to extraembryonic antigens in human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Review article: Fc gamma receptors in the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Trophoblast immunity in human pregnancy defined by antiidiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Anti-idiotype cancer vaccines: past and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

Anti-idiotype immunization of cancer patients: modulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1998.TB00332.X

10.1111/J.1600-0897.1998.TB00332.X

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference